Bevorzugter Name Batefenterol
IUPAC [1-[3-[2-chloro-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]-5-methoxyanilino]-3-oxopropyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
Englischer Name Batefenterol
Summenformel C40H42ClN5O7
Molmasse 740.24 Namen und Synonyme Batefenterol 743461-65-6 GSK-961081 GSK961081A GSK961081 1IAT42T80T GSK-961081A batefenterolum RefChem:116652 1-(2-((2-chloro-4-((((2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)carbamoyl)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate Batefenterol [USAN]
Weitere Namen anzeigen GSK-961081,Batefenterol Batefenterol(GSK961081) Batefenterol, 10 mM in DMSO GSK-961081(Batefenterol/TD-5959) GSK 961081 TD 5959 TD5959 Batefenterol, 98%, a novel muscarinic receptor antagonist and β2-adrenoceptor agonist GSK-961081,mAChR,inhibit,TD 5959,Muscarinic acetylcholine receptor,GSK 961081,Adrenergic Receptor,Batefenterol,Inhibitor,TD5959,Beta Receptor
MFCD27987925 TD-5959 Batefenterol (USAN) METHYL 6-{[(BENZYLOXY)CARBONYL]AMINOSPIRO[3.3]HEPTANE-2-CARBOXYLATE Carbamic acid, N-(1,1'-biphenyl)-2-yl-, 1-(3-((2-chloro-4-((((2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)-4-piperidinyl ester Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[3-[[2-chloro-4-[[[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl]amino]methyl]-5-methoxyphenyl]amino]-3-oxopropyl]-4-piperidinyl ester Batefenterol [USAN:INN] UNII-1IAT42T80T
Mehr laden (20 angezeigt)